Chugai Pharmaceutical to Run 3 Domestic Plants Instead of 2 (Japan)
This article was originally published in PharmAsia News
Chugai Pharmaceutical Co. has decided to continue operating one of its plants in Japan it was initially planning to close, saying it will run three plants instead of two. The Tokyo-based pharmaceutical maker, part of the Roche Holding AG group, announced in 2005 it would concentrate its domestic production facilities into two plants from five plants. However, it has now decided not to close its Tokyo plant, which the company discovered has a longer-than-expected lifespan for the production of biological products. (Click here for more - May Require Paid Subscription
You may also be interested in...
The German pricing and reimbursement system has been successful in recognizing the value and uniqueness of orphan drugs.
Erectile problems prevent a quarter of Brits from being intimate with a partner. Viatris' Upjohn - which markets Viagra Connect in the UK - is working with the Men’s Health Forum, sexual health charity Brook and dating expert Sarah Louise Ryan raise awareness of the problem and get men talking about the issue with their partners and with healthcare professionals.
Medtechs took a long look at themselves as they rose to the challenges of COVID-19. How they responded, repurposed and regrouped to tackle the coronavirus was both sobering and uplifting. The lessons of 2020 must be integrated into the digitally-enabled health care systems of 2021 and beyond.